NASDAQ:WDFC

WD-40 Down Ahead of Holiday Weekend
····

WD-40 Down Ahead of Holiday Weekend

WD-40 shares fell $2.71 to $205.30 late Thursday morning as consumer staples led S&P 500 sector losses and oil prices rose. The stock gave back part of Wednesday’s gain, trading about 1.3% below the prior close. WD-40 last reported higher quarterly sales and reaffirmed full-year guidance, but investors remain focused on cost and oil risks. Market value stood near $2.77 billion.
May 21, 2026

Stock Market Today

  • Genomic Test Could Spare Millions of Breast Cancer Patients Chemotherapy, Landmark Study Finds
    May 29, 2026, 8:16 PM EDT. A landmark study reveals that millions of breast cancer patients could safely skip chemotherapy thanks to the Prosigna genomic test, which analyses tumor genes to assess recurrence risk. The international OPTIMA trial, involving 4,429 patients, showed a 93.7% five-year cancer-free survival rate for those who avoided chemotherapy, nearly matching the 94.9% rate for those treated with it. Karen Bonham, a trial participant, described her relief upon learning she would not need chemotherapy, attributing her cancer-free status nine years post-diagnosis to the test's guidance. Experts hail the findings as gamechanging, potentially transforming breast cancer treatment by reducing unnecessary chemotherapy and its side effects, while maintaining patient safety.